Evidence map›Paper›PMID 42289709›Full record

ArticleJournal of nanobiotechnology2026

Food-grade TiO

Liang Lei, Aixiang Wang, Liping Dong, Tao Wu, Wenjuan He, Yonghui Yang, Jing Li, Xiaobin Bi, Yuan Cai, Xinlei Guan and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of nanobiotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Liang Lei *Central Laboratory, Wuhan Fourth Hospital, Wuhan, China.
Aixiang Wang *Department of Gastroenterology, Wuhan Fourth Hospital, Wuhan, China.
Liping Dong *Department of Clinical Nutrition, Wuhan Fourth Hospital, Wuhan, China.
Tao WuCentral Laboratory, Wuhan Fourth Hospital, Wuhan, China.
Wenjuan HeInstitute of Clinical Pharmacy, Wuhan Fourth Hospital, Wuhan, China.
Yonghui YangCentral Laboratory, Wuhan Fourth Hospital, Wuhan, China.
Jing LiPharmaceutical Department, Hubei Cancer Hospital, Wuhan, China.
Xiaobin BiSchool of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Yuan CaiDepartment of Nephrology, Wuhan Fourth Hospital, Wuhan, China. mrcai981@sina.com.
Xinlei GuanCentral Laboratory, Wuhan Fourth Hospital, Wuhan, China. xinleiguan@163.com.
Xiaoqiang ZhuCentral Laboratory, Wuhan Fourth Hospital, Wuhan, China. zhuxiaoqiang1992@126.com.

Funding

National Natural Science Foundation of China 82304152Natural Science Foundation (Exploration Project) of Wuhan City 2024040801020373Natural Science Foundation of Hubei Province 2023AFB392the Funding for Scientific Research Projects from Wuhan Municipal Health Commission WX23Q28
6 · The paper itself

Abstract

The use of titanium dioxide (TiO

Indexed as

Food AdditivesGastrointestinal MicrobiomeIndolesIntestinal MucosaMucinsTitaniumAnimalsHumansIntestinal Barrier FunctionMaleMiceQuercetinSulfatesFood AdditivesIndolesMucinsQuercetinSulfatesTitaniumtitanium dioxideFood additiveGut microbiotaILAIntestinal barrierMucin sulfationTiO2

Identifiers

PMID42289709
PMCPMC13495178

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.